Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

BACKGROUND: Bone metastases (BoM) are a negative prognostic factor in non-small-cell lung cancer (NSCLC). Beyond its supportive role, bone is a hematopoietic organ actively regulating immune system. We hypothesized that BoM may influence sensitivity to immunotherapy. METHODS: Pretreated non-squamous...

Descripción completa

Detalles Bibliográficos
Autores principales: Landi, Lorenza, D’Incà, Federica, Gelibter, Alain, Chiari, Rita, Grossi, Francesco, Delmonte, Angelo, Passaro, Antonio, Signorelli, Diego, Gelsomino, Francesco, Galetta, Domenico, Giannarelli, Diana, Soto Parra, Hector, Minuti, Gabriele, Tiseo, Marcello, Migliorino, Maria Rita, Cognetti, Francesco, Toschi, Luca, Bidoli, Paolo, Piantedosi, Francovito, Calabro’, Luana, Cappuzzo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868703/
https://www.ncbi.nlm.nih.gov/pubmed/31752994
http://dx.doi.org/10.1186/s40425-019-0793-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868703/
https://www.ncbi.nlm.nih.gov/pubmed/31752994
http://dx.doi.org/10.1186/s40425-019-0793-8

Ejemplares similares